Daniel Frigo

Has grant

Associate Professor

The University of Texas MD Anderson Cancer Center

United States

Research Interests

Explore related searches

Professors in United States Professors in Cancer Biology Cancer Biology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Daniel Frigo is an Associate Professor at The University of Texas MD Anderson Cancer Center in the United States. His research focuses on novel therapeutic approaches and metabolic dynamics in prostate cancer, with recent articles exploring topics such as ferroptosis, tumor metabolism, and the role of the androgen receptor in cancer biology. Frigo's work aims to uncover mechanisms that may lead to improved treatment strategies for advanced prostate cancer.

Recent Grants

Grant: Close

Therapeutic Targeting of Autophagy in Prostate Cancer

Open Date: 2016-07-01

Close Date: 2020-06-01

Grant: Close

Androgen Receptor- and Myc-Mediated Glutamine Metabolism in Prostate Cancer

Open Date: 2015-02-01

Close Date: 2017-01-31

Grant: Close

Genetic & Metabolic Dissection of the CaMKKbeta Signaling Axis in Prostate Cancer

Open Date: 2015-01-27

Close Date: 2019-12-31

Grant: Close

The CaMKK Beta-AMPK Signaling Axis as a Biomarker and Therapeutic Target for Advanced Prostate Cancer

Open Date: 2012-06-01

Close Date: 2015-05-31

Grant: Close

Modulation of Branched-Chain Fatty Acids for the Prevention of Prostate Cancer

Open Date: 2012-05-14

Close Date: 2015-04-30

Articles (17)

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Collaborators (15)

Thomas Scott

University of Virginia

UNITED STATES

Daniel Frigo

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (17)

Unlocking ferroptosis in prostate cancer — the road to novel therapies and imaging markers

Diet and Tumor Genetics Conspire to Promote Prostate Cancer Metabolism and Shape the Tumor Microenvironment

Adipose Triglyceride Lipase Is a Therapeutic Target in Advanced Prostate Cancer That Promotes Metabolic Plasticity

SGC-CAMKK2-1: A Chemical Probe for CAMKK2

Architecture of androgen receptor pathways amplifying glucagon-like peptide-1 insulinotropic action in male pancreatic β cells

Stranger Things: New Roles and Opportunities for Androgen Receptor in Oncology Beyond Prostate Cancer

The androgen receptor does not directly regulate the transcription of DNA damage response genes.

Cancer Cell–Extrinsic Roles for the Androgen Receptor in Prostate Cancer

Characterization of prostate cancer adrenal metastases: dependence upon androgen receptor signaling and steroid hormones

Editorial: Metabolic regulation under oxidative stress in cancer

Systemic Ablation of Camkk2 Impairs Metastatic Colonization and Improves Insulin Sensitivity in TRAMP Mice: Evidence for Cancer Cell-Extrinsic CAMKK2 Functions in Prostate Cancer

Regulation and role of CAMKK2 in prostate cancer

Steroid Hormones and Receptors in Health and Disease

Nuclear receptors: from molecular mechanisms to therapeutics

A simple quantitative PCR assay to determine TRAMP transgene zygosity

Mitochondria in Metabolic Syndrome, Reproduction and Transgenerational Inheritance—Ongoing Debates and Emerging Links

Chronic IL-1 exposure drives LNCaP cells to evolve androgen and AR independence

Collaborators (15)

Thomas Scott

Katherine Kurnit

Kaitlin J Basham

Weiwei Xu

David H. Drewry

John Scott

Opher Gileadi

Charles Burant

Eleonora Dondossola

Shannon Westin

Nikki Delk

Zeynep Madak-Erdogan

David Hodson

Carrow Wells

Jon Oakhill

Make your next move.